Beyond Air Inc. (NASDAQ: XAIR) announced that its proposed transaction to sell NeuroNOS subsidiary to XTL Biopharmaceuticals Ltd. has been ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Mergers and Acquisitions